芒果超媒(300413.SZ):持續關注研究包括AI在內的行業相關新技術發展
格隆匯4月27日丨芒果超媒(300413.SZ)在4月25日15:00-16:00業績説明上表示,有投資者問到“AIGC快速發展,公司未來如何考慮與AI技術結合,賦能公司業務?”公司迴應,公司持續關注研究包括AI在內的行業相關新技術發展。公司一直保持對行業相關新技術的研發投入,公司創新研究院長期以來專門進行新技術研發並取得了多項技術應用的落地實施。媒體行業的大發展,歷來都是由於技術創新所推動的,公司積極擁抱新技術,包括ChatGPT等新型AI技術在內,我們都做了很多相關研究,並積極嘗試依託新技術來實驗節目模式的再次創新。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.